Dampier Carlton, Jaeger Byron, Gross Heather E, Barry Vaughn, Edwards Lloyd, Lui Yang, DeWalt Darren A, Reeve Bryce B
Department of Pediatrics, Emory Children's Center, Emory University School of Medicine, Atlanta, Georgia.
AFLAC Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Pediatr Blood Cancer. 2016 Jun;63(6):1038-45. doi: 10.1002/pbc.25931. Epub 2016 Feb 8.
The Patient-Reported Outcomes Measurement Information System(®) (PROMIS(®) ) created pediatric self-report scales measuring a variety of health attributes (domains), but their responsiveness to changes in health status has not yet been determined in children with sickle cell disease (SCD).
A convenience cohort of symptomatic SCD children, aged 8-17 years, was asked to complete PROMIS pediatric scales at an initial clinic visit, at the end of a subsequent hospitalization for sickle pain, at a subsequent clinic visit or at home 2-3 weeks after hospitalization, and at a clinic visit 1-2 years after their initial assessment.
A total of 121 participants (mean age 12.5 ± 3.1 years, 56.2% female) participated in the study. Pain interference and fatigue domain scores were elevated at baseline, increased substantially during hospitalization, and largely returned to baseline by the recovery period, whereas the depressive symptoms, anger, and anxiety domain scores displayed a less pronounced elevation during hospitalizations and a slower return to baseline levels. The two physical functioning scales showed a substantial decline in response to hospitalization, but only modest improvements at the recovery assessment, likely representing incomplete recovery.
Several PROMIS pediatric measures were responsive to changes in health status associated with occurrence and resolution of acute vaso-occlusive pain requiring hospitalization. The substantial differences in these domains during SCD-related pain exacerbations support their potential usefulness in clinical research or in clinical practice. Further studies to characterize variations in symptom patterns over time may provide insights into strategies for more effective management of sickle pain.
患者报告结局测量信息系统(PROMIS)开发了测量多种健康属性(领域)的儿科自我报告量表,但尚未在镰状细胞病(SCD)患儿中确定其对健康状况变化的反应性。
选取了一组8至17岁有症状的SCD患儿作为便利样本,要求他们在初次门诊就诊时、随后因镰状细胞疼痛住院结束时、住院后2至3周的后续门诊就诊或家中以及初次评估后1至2年的门诊就诊时完成PROMIS儿科量表。
共有121名参与者(平均年龄12.5±3.1岁,56.2%为女性)参与了该研究。疼痛干扰和疲劳领域得分在基线时升高,住院期间大幅增加,到恢复期基本恢复到基线水平,而抑郁症状、愤怒和焦虑领域得分在住院期间升高不太明显,恢复到基线水平的速度较慢。两个身体功能量表显示因住院而大幅下降,但在恢复评估时仅有适度改善,这可能代表恢复不完全。
几种PROMIS儿科测量方法对与需要住院治疗的急性血管阻塞性疼痛的发生和缓解相关的健康状况变化有反应。在SCD相关疼痛加重期间这些领域的显著差异支持了它们在临床研究或临床实践中的潜在用途。进一步研究以表征症状模式随时间的变化可能会为更有效管理镰状细胞疼痛的策略提供见解。